Tier 2 Testing of Biodiesel Exhaust Emissions

Total Page:16

File Type:pdf, Size:1020Kb

Tier 2 Testing of Biodiesel Exhaust Emissions Final Report Protocol FY98-056 FINAL REPORT TIER 2 TESTING OF BIODIESEL EXHAUST EMISSIONS Study Report Number FY98-056 Submitted to: National Biodiesel Board (NBB) 1907 Williams Street - P.O. Box 104898 Jefferson City, Missouri 65110 Submitted by: Lovelace Respiratory Research Institute (LRRI) P.O. Box 5890 Albuquerque, NM 87185-5890 May 22, 2000 Total numbers of pages 1005 1 Final Report Protocol FY98-056 TABLE OF CONTENTS Page TABLE OF CONTENTS.................................................................................................................2 COMPLIANCE STATEMENT.......................................................................................................7 LIST OF ACRONYMS ...................................................................................................................8 CONTRIBUTING LRRI PERSONNEL .........................................................................................9 SUBCONTRACTING CONTRIBUTORS .....................................................................................9 REPORT SIGNATURES ..............................................................................................................10 QUALITY ASSURANCE STATEMENT ....................................................................................11 TEST MATERIALS CHARACTERIZATION/STABILITY.......................................................12 ARCHIVAL STORAGE ...............................................................................................................12 SUMMARY...................................................................................................................................13 I. INTRODUCTION .............................................................................................................14 II. MATERIALS AND METHODS.......................................................................................14 A. Study Dates ............................................................................................................14 B. Protocol and Experimental Design ........................................................................14 C. Test Fuel Characterization .....................................................................................14 D. Exposure Generation System.................................................................................14 E. Animals and Animal Husbandry............................................................................17 F. Animal Exposures..................................................................................................18 G. Body Weights.........................................................................................................18 H. Mortality and Clinical Observations......................................................................19 I. Feed Consumption .................................................................................................19 J. Ophthalmologic Evaluation ...................................................................................20 K. Positive Control Study of Neuropathologic Lesions in Acrylamide-Treated Rats ........................................................................................................................20 L. General Histology Group.......................................................................................22 M. Special Histology Group........................................................................................22 N. Clinical Pathology..................................................................................................22 O. Glial Fibrillary Acidic Protein Assay ....................................................................26 P. Micronucleus Assay...............................................................................................26 Q. Sister Chromatid Exchange Assay.........................................................................27 R. Individual Animal Fertility ....................................................................................28 S. Reproductive Toxicology and Teratology .............................................................29 T. Salmonella Typhimurium Reverse Mutation Assay...............................................29 III. RESULTS AND DISCUSSION........................................................................................31 A. Test Fuel Characterization .....................................................................................31 B. Animals and Animal Husbandry............................................................................31 C. Animal Exposures..................................................................................................31 D. Body Weights.........................................................................................................35 E. Mortality and Clinical Observations......................................................................35 2 Final Report Protocol FY98-056 F. Feed Consumption .................................................................................................36 G. Ophthalmologic Evaluation ...................................................................................36 H. General Histology Group.......................................................................................37 I. Special Histology Group........................................................................................42 J. Histology Discussion .............................................................................................44 K. Clinical Chemistry .................................................................................................45 L. Hematology............................................................................................................46 M. Glial Fibrillary Acidic Protein Assay ....................................................................47 N. Micronucleus Assay...............................................................................................48 O. Sister Chromatid Exchange Assay.........................................................................50 P. Individual Animal Fertility ....................................................................................52 Q. Reproductive Toxicology and Teratology .............................................................53 R. Mutagenicity Testing .............................................................................................53 IV. CONCLUSIONS................................................................................................................54 V. REFERENCES ..................................................................................................................58 LIST OF TABLES AND FIGURES Table Page 1 Experimental design for Tier 2 study.................................................................................15 2 Animal numbers and assignments for Tier 2 study. ..........................................................16 3 Cerebellar lesions found in acrylamide-treated rats...........................................................21 4 Criteria for severity grading of lung lesions. .....................................................................23 5 Clinical chemistry analytical methods...............................................................................25 6 Hematology tests................................................................................................................25 7 Summary of NOx concentration data. ................................................................................32 8 Summary of particulate and gas analyte concentration data..............................................32 9 Particle size distribution of biodiesel exhaust particulates measured at two times during the study..................................................................................................................34 10 Organs examined at histology............................................................................................38 11 Incidence and severity of lung lesions after 13 weeks of exposure...................................38 12 Comparison of lung lesions after 13 weeks of high-level exposure and 13 weeks of high-level exposure with 28 days recovery. ..................................................................42 13 Clinical chemistry data analysis.........................................................................................46 14 Summary data for glial fibrillary acidic protein assay.......................................................47 15 Summary data for micronucleus evaluation from bone marrow cells from biodiesel study rats.............................................................................................................49 16 Summary data for sister chromatid exchange assay. .........................................................51 3 Final Report Protocol FY98-056 Figure Page 1 An increased number of AMs containing black particles was characteristic of the lung lesions in the rats exposed to the high concentration.................................................39 2 AMs in the rats in the highest exposure concentration contained many black particles that obscured the cellular details and nucleus of the cell (arrows)......................40 3 Alveolar bronchiolarization (arrows), lining of ADs and alveoli adjacent to TBs with ciliated and Clara cells, was seen in a few airways of rats in the highest exposure
Recommended publications
  • Evaluation of Genotoxicity and Cytotoxicity Amongst in Dental
    Dental, Oral and Craniofacial Research Research Article ISSN: 2058-5314 Evaluation of genotoxicity and cytotoxicity amongst in dental surgeons and technicians by micronucleus assay Molina Noyola Leonardo Daniel1,2, Coronado Romo María Eugenia3, Vázquez Alcaraz Silverio Jafet4, Izaguirre Pérez Marian Eliza1,2, Arellano-García Evarista5, Flores-García Aurelio6 and Torres Bugarín Olivia1* 1Laboratorio de Evaluación de Genotóxicos, Programa Internacional de Medicina, Universidad Autónoma de Guadalajara, Mexico 2Facultad de Medicina, Universidad Autónoma de Guadalajara, Mexico 3Departamento de Ortodoncia, Facultad de Odontología, Universidad Autónoma de Guadalajara, Mexico 4Departamento de Endodoncia, Facultad de Odontología, Universidad Autónoma de Guadalajara, Mexico 5Facultad de Ciencias, Universidad Autónoma de Baja California, Mexico 6Unidad Académica de Medicina, Universidad Autónoma de Nayarit, Tepic, Nayarit, Mexico Abstract Introduction: Dental surgeons and technicians are continuously exposed to agents could be affect the genetic material and induce mutations. The aim of this study was to evaluate the genotoxic and cytotoxic occupational risk of dental surgeons and technicians through the micronucleated cells (MNC) and nuclear abnormalities (NA) assay in oral mucosa. Methods: Case-control study. We have collected a buccal mucosa from dental surgeons, dental technicians and healthy individuals (matched by BMI, age and gender). The smears were fixed (ethanol 80%/48 h), stained (orange acridine) and analyzed (microscope, 100×). The frequency of MNC and NA (binucleated cells [BNC], lobulated nucleus [LN], condensed chromatins [CC], karyorrhexis [KR], pyknosis (PN) and karyolysis [KL] were counted in 2,000 cells per participant. Results: 90 samples were collected (26 surgeons, 19 technicians and 45 controls). Compared with controls, exception of PN, in surgeons was higher frequency and positive association of MNC and all NA (p<0.05).
    [Show full text]
  • 71182407Ad80c7abf430b599eb
    Journal name: International Journal of Nanomedicine Article Designation: Original Research Year: 2017 Volume: 12 International Journal of Nanomedicine Dovepress Running head verso: Yang et al Running head recto: HA-SPIONs for effective cancer diagnosis and treatment open access to scientific and medical research DOI: http://dx.doi.org/10.2147/IJN.S121249 Open Access Full Text Article ORIGINAL RESEARCH Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy Rui-Meng Yang1,* Abstract: Theranostic nanoparticles with both imaging and therapeutic abilities are highly Chao-Ping Fu2,* promising in successful diagnosis and treatment of the most devastating cancers. In this study, Jin-Zhi Fang1 the dual-modal imaging and photothermal effect of hyaluronan (HA)-modified superparamag- Xiang-Dong Xu1 netic iron oxide nanoparticles (HA-SPIONs), which was developed in a previous study, were Xin-Hua Wei1 investigated for CD44 HA receptor-overexpressing breast cancer in both in vitro and in vivo Wen-Jie Tang1 experiments. Heat is found to be rapidly generated by near-infrared laser range irradiation of HA- SPIONs. When incubated with CD44 HA receptor-overexpressing MDA-MB-231 cells in vitro, Xin-Qing Jiang1 HA-SPIONs exhibited significant specific cellular uptake and specific accumulation confirmed Li-Ming Zhang2 by Prussian blue staining. The in vitro and in vivo results of magnetic resonance imaging and 1Department of Radiology, Guangzhou photothermal ablation demonstrated that HA-SPIONs exhibited significant negative contrast First People’s Hospital, Guangzhou enhancement on T -weighted magnetic resonance imaging and photothermal effect targeted Medical University, 2School of 2 Materials Science and Engineering, CD44 HA receptor-overexpressing breast cancer.
    [Show full text]
  • 1 Pathology Week 1 – Cellular Adaptation, Injury and Death
    Pathology week 1 – Cellular adaptation, injury and death Cellular responses to injury Cellular Responses to Injury Nature and Severity of Injurious Stimulus Cellular Response Altered physiologic stimuli: Cellular adaptations: • ↑demand, ↑ trophic stimulation (e.g. growth factors, hormones) • Hyperplasia, hypertrophy • ↓ nutrients, stimulation • Atrophy • Chronic irritation (chemical or physical) • Metaplasia Reduced oxygen supply; chemical injury; microbial infection Cell injury: • Acute and self-limited • Acute reversible injury • Progessive and severe (including DNA damage) • Irreversible injury → cell death Necrosis Apoptosis • Mild chronic injury • Subcellular alterations in organelles Metabolic alterations, genetic or acquired Intracell accumulations; calcifications Prolonged life span with cumulative sublethal injury Cellular aging Hyperplasia - response to increased demand and external stimulation - ↑ number cells - ↑ volume of organ - often occurs with hypertrophy - occurs if cells able to synthesize DNA – mitotic division - physiologic or pathologic Physiological hyperplasia A) hormonal – ↑ functional capacity tissue when needed (breast in puberty, uterus in pregnancy) B) compensatory - ↑ tissue mass after damage/resection (post-nephrectomy) Mechanisms: - ↑ local production growth factors or activation intracellular signaling pathways o both → production transcription factors that turn on cellular genes incl those encoding growth factors, receptors for GFs, cell cycle regulators →→ cellular proli feration - in hormonal hyperplasia
    [Show full text]
  • Cytology of Inflammation
    Association of Avian Veterinarians Australasian Committee Ltd. Annual Conference Proceedings Auckland New Zealand 2017 25: 20-30 Cytology of Inflammation Terry W. Campbell MS, DVM, PhD, Emeritus Department of Clinical Sciences College of Veterinary Medicine and Biomedical Sciences Colorado State University 300 West Drake Road Fort Collins, Colorado, USA The inflammatory response of birds can be classified as a mixed cell inflammation, the most common cellular in- either heterophilic, eosinophilic (rarely reported as they flammatory response seen in birds. They can develop into may be difficult to detect with routine staining), mixed epithelioid and multinucleated giant cells. As the inflam- cell, or macrophagic (histiocytic) depending upon the pre- matory process continues and becomes chronic, granu- dominant cell type. Inflammatory cells arrive at the lesion lomas may develop as the macrophages form into layers by active migration in response to various chemotactic that resemble epithelium and this is the reason for the factors, and the type of inflammatory response present term “epithelioid cells.” As the lesion matures, fibroblasts may suggest a possible aetiology and pathogenesis. proliferate and begin to lay down collagen. These prolif- erating fibroblasts appear large compared to the small Heterophilic Inflammation of Birds densely staining fibroblasts of normal fibrous tissue. Lym- phocytes appear within the stroma and participate in the Inflammation occurs whenever chemotactic factors for cell-mediated immune response. Fusion of macrophages inflammatory cells are released. The most common caus- into giant cells occurs in association with material that is es are microbes and their toxins, physical and chemical not readily digested by macrophages. The results of acute trauma, death of cells from circulatory insufficiency, and inflammation may be complete resolution, development immune reactions.
    [Show full text]
  • Anal Cytology in Women with Cervical Intraepithelial Or Invasive Cancer
    ORIGINAL ARTICLE J Bras Patol Med Lab, v. 51, n. 5, p. 315-322, October 2015 Anal cytology in women with cervical intraepithelial or invasive cancer: interobserver agreement Citologia anal em mulheres com neoplasia intraepitelial ou invasiva cervical: concordância interobservadores 10.5935/1676-2444.20150051 Sandra A. Heráclio1; Fátima Regina G. Pinto2; Kristiane Cahen2; Letícia Katz2; Alex Sandro R. Souza1, 3 1. Instituto de Medicina Integral Professor Fernando Figueira (Imip). 2. Laboratório Central de Saúde Pública de Pernambuco (Lacen-PE). 3. Universidade Federal de Pernambuco (UFPE). ABSTRACT Introduction: Incidence rates of anal cancer have been rising worldwide in the last 20 years. Due to embryological, histological and immunohistochemical similarities between the anal canal and the cervix, routine screening with anal cytology for precursor lesions in high-risk groups has been adopted. Objective: To determine interobserver agreement for the diagnosis of anal neoplasia by anal cytology. Material and methods: A cross-sectional observational study was conducted in 324 women with cervical intraepithelial or invasive cancers, for screening of anal cancer, from December 2008 to June 2009. Three hundred twenty-four cytological samples were analyzed by three cytopathologists. Cytological evaluation was based on the revised Bethesda terminology; samples were also classified into negative and positive for atypical cells. We calculated the kappa statistic with 95% confidence interval (95% CI) to assess agreement among the three cytopathologists. Results: Interobserver agreement in the five categories of the Bethesda terminology was moderate (kappa for multiple raters: 0.6). Agreement among cytopathologists 1, 2 and 3 with a consensus diagnosis was strong (kappa: 0.71, 0.85 and 0.82, respectively).
    [Show full text]
  • Chapter 1 Cellular Reaction to Injury 3
    Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1).
    [Show full text]
  • Salivary Gland – Necrosis
    Salivary Gland – Necrosis Figure Legend: Figure 1 Salivary gland - Necrosis in a male F344/N rat from a subchronic study. There is necrosis of the acinar cells (arrow) with inflammation. Figure 2 Salivary gland - Necrosis in a male F344/N rat from a subchronic study. There is necrosis of the acinar cells (arrow) with chronic active inflammation. Figure 3 Salivary gland - Necrosis in a female F344/N rat from a subchronic study. There is necrosis of an entire lobe of the salivary gland (arrow), consistent with an infarct. Figure 4 Salivary gland - Necrosis in a female F344/N rat from a subchronic study. There is necrosis of all the components of the salivary gland (consistent with an infarct), with inflammatory cells, mostly neutrophils. Comment: Necrosis may be characterized either by scattered single-cell necrosis or by locally extensive areas of necrosis involving contiguous cells or structures. Single-cell necrosis can present as cell shrinkage, condensation of nuclear chromatin and cytoplasm, convolution of the cell, and the presence of apoptotic bodies. Acinar necrosis can present as focal to multifocal areas characterized by 1 Salivary Gland – Necrosis tissue that is paler than the surrounding viable tissue, consisting of swollen cells with variable degrees of eosinophilia, hyalinized cytoplasm, vacuolated cytoplasm, nuclear pyknosis, karyolysis, and/or karyorrhexis with associated cellular debris (Figure 1 and Figure 2). Secondary inflammation is common. Infarction (Figure 3 and Figure 4) is characterized by a focal to focally extensive area of salivary gland necrosis. One cause of necrosis, inflammation, and atrophy of the salivary gland in the rat is an active sialodacryoadenitis virus infection, but this virus does not affect the mouse salivary gland.
    [Show full text]
  • Evaluation of Various Nuclear Cytological Changes in Normal
    Hindawi Publishing Corporation Pathology Research International Volume 2016, Article ID 6293795, 8 pages http://dx.doi.org/10.1155/2016/6293795 Research Article Evaluation of Various Nuclear Cytological Changes in Normal Buccal Mucosa and Peritumoural Area in Patients with Oral Squamous Cell Carcinoma Receiving Concomitant Chemoradiotherapy Sadia Minhas,1 Muhammad Kashif,2 andA.H.Nagi3 1 Department of Oral Pathology, Akhtar Saeed Medical and Dental College, Bahria Town, Lahore 54000, Pakistan 2Department of Immunology, University of Health Sciences, Lahore, Pakistan 3Department of Morbid Anatomy and Histopathology, University of Health Sciences, Lahore, Pakistan Correspondence should be addressed to Sadia Minhas; [email protected] Received 13 October 2015; Accepted 30 March 2016 Academic Editor: Elizabeth Wiley Copyright © 2016 Sadia Minhas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objectives. To evaluate the role of serial cytological assay in calculating the nuclear response of contralateral normal buccal mucosa and peritumoural area of squamous cell carcinoma of oral cavity in patients receiving fractionated radiotherapy (RT) and chemotherapy. Materials and Methods. This prospective, nonrandomized study wasmprised co of 76 histologically confirmed cases of oral squamous cell carcinoma on cyclical chemoradiation treatment. Chemoradiosensitivity was evaluated using serial scrape smears taken before and after immediate exposure to CCRT, at 17th day of CCRT (mid of treatment), and at the end of treatment. The nuclear changes, such as multinucleation, micronucleation, karyorrhexis, karyolysis, nuclear budding, prominent nucleoli, and binucleation occurring in both irradiated cancer cells and contralateral normal buccal mucosa, had a statistically significant dose related increase with concomitant chemoradiotherapy ( < 0.05).
    [Show full text]
  • Necrosis. Apoptosis
    Lethal cell damage. Necrosis. Apoptosis. Lecture 3 Mavlikeev M.O. Damage (injury) Nomenclature Committee on Cell Death 2018 RCD: Regulated cell death, ADCD: autophagy- dependent cell death, ICD: immunogenic cell death, LDCD: lysosome- dependent cell death, MPT: mitochondrial permeability transition. Local death There are two types of the local death, i.e. destruction of structures in the living organism: necrosis (of cell and tissues), apoptosis (of cell). Necrosis Necrosis - one type of local death, which can involve cells, groups of cells, tissues, organs, and occurs in the presence of strong disturbing factors. The concept of “necrosis" is a subtype of the more general concept of "death". Etiological types of necrosis Traumatic necrosis Occurs by the action of physical (mechanical, thermal, radiation) and chemical (acids, alkalis, etc.) factors. Toxic necrosis Occurs by the action of bacterial toxins and toxins of other origins. Trophoneurotic necrosis Associated with the violation of microcirculation and innervation of the tissue in chronic diseases (bedsores). Allergic necrosis Develops in immunopathological reactions (Arthus phenomenon). Vascular (ischemic) necrosis It is connected with the violation of the blood supply to an organ or tissue. Subtypes of necrosis Depending on the mechanism of action of the etiological factors there are the following types of necrosis: Direct necrosis direct action on the tissue in traumatic and toxic damage. Indirect necrosis Indirect effects through the vascular, nervous and immune systems. Morphogenesis of necrosis There are the following stages of the development of necrosis. I. Paranecrosis Reversible necrosis-like changes. II. Bionecrosis Irreversible degenerative changes. III. Cell death Criteria for establishing the time of cell death currently do not exist.
    [Show full text]
  • Apoptotic Bodies Due to Erythema Multiforme: Cytological, Histopathological and Immunofluorescence Findings
    142 Turk J Dermatol 2017;11:142-3 Pearls in Dermatology / Dermatolojik İnciler Murat Durdu Apoptotic Bodies due to Erythema Multiforme: Cytological, Histopathological and Immunofluorescence Findings A 12-year-old male patient was admitted with alopecic patches on the scalp. In his history, he had been diagnosed with alopecia areata for two years. Despite topical steroid creams and intralesional steroid injections, he continued to develop new alopecic patches. Topical immunotherapy with diphencyprone (DPCP) was planned due to severe (>50% involvement) alopecia areata lesions. Sensitization with 2% DPCP solution was applied to the occipital region. Two days later, vesicular and bullous lesions on the erythematous base developed on the sensitization site. One week later, erythematous target-like papules and plaques localized on the occipital region and back of the neck (Figure 1a). There were vesicles in the mid of some papules. Skin scraping smear from the vesicular lesions were taken and the smears were stained with the Papanicolaou (PAP) stain. Cytological examination showed apoptotic bodies characterized by karyolysis, karyorrhexis, and pyknosis in the keratinocytes (Figure 1b). Histopathological examination of the punch biopsy specimens revealed epidermal apoptotic cells (Figure 1c). Hematoxylin and eosin (H&E) stained specimens were evaluated using immunofluorescence microscopy and autofluorescence was obtained from Başkent University Faculty of Medicine, Adana Dr. Turgut Noyan Application and Research Center, Clinic of Dermatology, Adana, Turkey Correspondence/ Yazışma Adresi: Murat Durdu, Başkent University Faculty of Medicine, Adana Dr. Turgut Noyan Application and Research Center, Clinic of Dermatology, Adana, Turkey Phone: +90 322 327 27 27 E-mail: [email protected] Figure 1. Clinical, cytological, histopathological, and immunofluorescence microscopic ORCID ID: findings of a case with erythema multiforme.
    [Show full text]
  • Cell Injury David S
    91731_ch01 12/1/06 10:10 AM Page 1 1 Cell Injury David S. Strayer Emanuel Rubin Reactions to Persistent Stress and Cell Injury Ionizing Radiation Proteasomes Viral Cytotoxicity Atrophy as Adaptation Chemicals Atrophy as an Active Process Abnormal G Protein Activity Hypertrophy Cell Death Hyperplasia Morphology of Necrosis Metaplasia Necrosis from Exogenous Stress Dysplasia Necrosis from Intracellular Insults Calcification Apoptosis (Programmed Cell Death) Hyaline Initiators of Apoptosis Mechanisms and Morphology of Cell Injury Biological Aging Hydropic Swelling Maximal Life Span Subcellular Changes Functional and Structural Changes Ischemic Cell Injury The Cellular Basis of Aging Oxidative Stress Genetic Factors Nonlethal Mutations that Impair Cell Function Somatic Damage Intracellular Storage Summary Hypothesis of Aging Ischemia/Reperfusion Injury athology is basically the study of structural and functional ab- between its internal milieu and a hostile environment. The normalities that are expressed as diseases of organs and systems. plasma membrane serves this purpose in several ways: PClassic theories of disease attributed disease to imbalances • It maintains a constant internal ionic composition against or noxious effects of humors on specific organs. In the 19th cen- very large chemical gradients between the interior and exte- tury, Rudolf Virchow, often referred to as the father of modern rior compartments. pathology, proposed that injury to the smallest living unit of the body, the cell, is the basis of all disease. To this day, clinical and • It selectively admits some molecules while excluding or ex- experimental pathology remain rooted in this concept. truding others. Teleology—the study of design or purpose in nature—has • It provides a structural envelope to contain the informa- long since been discredited as part of scientific investigation.
    [Show full text]
  • Lung, Epithelium – Necrosis
    Lung, Epithelium – Necrosis Figure Legend: Figure 1 Lung, Bronchiole, Epithelium, Bronchiole - Necrosis in a female B6C3F1/N mouse from a subchronic study. The epithelial cells are fragmented, with pyknotic and karyorrhectic nuclei. Figure 2 Lung, Epithelium - Necrosis in a male Wistar Han rat from a chronic study. There is a large area of coagulative necrosis surrounded by suppurative inflammation. Figure 3 Lung, Epithelium, Alveolus - Necrosis in a female F344/N rat from a subchronic study. There is loss of epithelial cells, and many of the interstitial cells have pyknotic nuclei. Figure 4 Lung, Epithelium, Alveolus - Necrosis in a female F344/N rat from a subchronic study. In this focal lesion, there is loss of epithelial and interstitial cells. Comment: Necrosis (Figure 1, Figure 2, Figure 3, and Figure 4) and degeneration are considered to be parts of the continuum of cell damage, with necrosis representing irreversible cell damage and 1 Lung, Epithelium – Necrosis degeneration representing reversible cell damage. The light microscopic features of necrosis include nuclear pyknosis, karyorrhexis, or karyolysis, cell swelling, loss of cellular detail, cell fragmentation, and cytoplasmic hypereosinophilia (in which the cytoplasm often has a homogeneous appearance). Large areas of necrosis (Figure 2, Figure 3, and Figure 4) may also have disrupted tissue architecture, large areas of necrotic debris, loss of staining intensity, and inflammatory cells. Necrosis of the epithelial cells lining the airways as a result of toxic injury is often characterized by sloughing of necrotic cells or cellular debris into the lumen. The light microscopic hallmarks of reversible cell damage include cellular swelling, cytoplasmic vacuolation, perinuclear clear spaces, formation of cytoplasmic blebs, loss of normal apical blebs from Clara cells, and loss of cilia.
    [Show full text]